Deciphering key chemotherapeutic drug targets within tyrosine metabolism for breast cancer and advancing a wide-ranging diagnostic strategy
This research provides an effective model for the prognostic assessment and early diagnosis of breast cancer, opening new avenues for research into the precision treatment of breast cancer and the management of chemotherapy side effects.
Authors
- Zilu Xie
- Shuang Cao (ORCID: https://orcid.org/0000-0002-1855-3426)
- Dan Lü (ORCID: https://orcid.org/0000-0002-5204-2574)
- Huanhuan Shi (ORCID: https://orcid.org/0000-0003-2570-4226)
- Jinsong Yan (ORCID: https://orcid.org/0000-0003-4109-2602)
- Di Chen (ORCID: https://orcid.org/0000-0002-2181-4703)
- Yi Chen (ORCID: https://orcid.org/0000-0002-0528-5776)
- Shaofeng Jiang (ORCID: https://orcid.org/0000-0002-0550-9565)
- Renliang Wu
Institutions
- Hubei Provincial Women and Children's Hospital (CN)
- Wuhan Children's Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Nanchang Hangkong University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1007/s12672-025-03577-x
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Nanchang Hangkong University
- Natural Science Foundation of Hubei Province